K
Kathryn Anastos
Researcher at Albert Einstein College of Medicine
Publications - 394
Citations - 15007
Kathryn Anastos is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Population. The author has an hindex of 59, co-authored 351 publications receiving 13391 citations. Previous affiliations of Kathryn Anastos include Lincoln Hospital & Capital Medical University.
Papers
More filters
Journal ArticleDOI
Perceived and posttraumatic stress is associated with decreased learning, memory, and fluency in HIV-infected women
Leah H. Rubin,Leah H. Rubin,Judith A. Cook,Gayle Springer,Kathleen M. Weber,Mardge H. Cohen,Eileen M. Martin,Victor Valcour,Lorie Benning,Christine Alden,Joel Milam,Kathryn Anastos,Mary Young,Deborah Gustafson,Erin E. Sundermann,Pauline M. Maki +15 more
TL;DR: More than depression, perceived stress and PTSD symptoms are treatment targets to potentially improve fluency, learning, and memory in women living with HIV particularly when HIV treatment is not optimal.
Journal ArticleDOI
Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.
Monica Gandhi,Leslie Z. Benet,Peter Bacchetti,Ann Kalinowski,Kathryn Anastos,Alan R. Wolfe,Mary Young,Mardge H. Cohen,Howard Minkoff,Stephen J. Gange,Ruth M. Greenblatt +10 more
TL;DR: This study identifies and quantitates previously unrecognized factors modifying NNRTI exposure in the “real-world” setting and may ultimatley lead to dose optimization strategies in patients at risk for failure or adverse events.
Journal ArticleDOI
Detectability and reproducibility of plasma levels of chemokines and soluble receptors
Ilir Agalliu,Xiaonan Xue,Mary Cushman,Elaine Cornell,Ann W. Hsing,Robert C. Kaplan,Kathryn Anastos,Swapnil Rajpathak,Gloria Y.F. Ho +8 more
TL;DR: Multiplex assays for plasma levels of selected chemokines and soluble receptors showed good to excellent assay detectability and repeatability, indicating that a single measurement of these analytes may be used to assess biomarker-disease associations.
Journal ArticleDOI
Frontline Science: CXCR7 mediates CD14+CD16+ monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS
Mike Veenstra,Dionna W. Williams,Tina M. Calderon,Kathryn Anastos,Susan Morgello,Joan W. Berman +5 more
TL;DR: It is proposed that CXCR7 is a therapeutic target on CD14+CD16+ monocytes to limit their CNS entry, thereby reducing neuroinflammation, neuronal damage, and HIV‐associated neurocognitive disorders.
Journal ArticleDOI
Serum Biomarkers of Immune Activation and Subsequent Risk of Non-Hodgkin B-Cell Lymphoma among HIV-Infected Women
Shehnaz K. Hussain,Nancy A. Hessol,Alexandra M. Levine,Alexandra M. Levine,Elizabeth C. Breen,Kathryn Anastos,Mardge H. Cohen,Gypsyamber D'Souza,Deborah Gustafson,Sylvia Silver,Otoniel Martinez-Maza +10 more
TL;DR: The hypothesis that chronic B-cell activation contributes to the development of AIDS-NHL in women is supported, and Soluble CD23 (sCD23), sCD27, sCD30, and CXCL13 may serve as biomarkers for AIDS-nHL.